Publications by authors named "Zeying Yan"

Claim this Profile
D
Differences in response to immunotherapy drugs including blinatumomab and inotuzumab ozogamicin in B-ALL patients.
Zhi-Yin Liu, Ze-Ying Yan, Jian-Feng Li, Yong-Mei Zhu, Guang Yang

Int J Hematol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy related acute myeloid leukemia secondary to CAR-T therapy in refractory/relapsed multiple myeloma patient showing poor prognosis.
Ran An, Weiying Bao, Zeying Yan, Haimin Sun, Xiaoqian Xu

Ann Hematol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A patient with positive anti-IFN-γ autoantibody and monoclonal gammaglobulinemia masquerading as multiple myeloma: Case report and literature review.
Ran An, Zhiyin Liu, Fangxiu Luo, Zeying Yan, Ying Wang

Clin Case Rep· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
may indicate a new subgroup of acute leukemias with miscellaneous immunophenotype and poor initial treatment response but showing sensitivity to venetoclax.
Haimin Sun, Yongmei Zhu, Jianfeng Li, Lingling Zhao, Guang Yang, Zeying Yan

EJHaem· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The landscape of NUP98 rearrangements clinical characteristics and treatment response from 1491 acute leukemia patients.
Jie Tian, Yongmei Zhu, Jianfeng Li, Guang Yang, Xiangqin Weng, Zeying Yan

Blood Cancer J· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CSF3R P733T is a deleterious germline variant in acute leukaemia showing gain-of-function-like T618I mutation.
Haimin Sun, Yongmei Zhu, Jianfeng Li, Lingling Zhao, Zeying Yan

Br J Haematol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Experience of PD-1 Inhibitors for Relapsed and Refractory Hodgkin Lymphoma: A Multicenter Retrospective Analysis of Patients in China.
Wenyan Yu, Mei Geng, Jie Hao, Zeying Yan, Jian-Qing Mi

Acta Haematol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute myeloid leukemia patients with NUP98::NSD1 showing initially poor treatment response can benefit from FLT3 inhibitors and venetoclax as well as HSCT.
Haimin Sun, Han Yan, Zeying Yan, Yongmei Zhu, Guang Yang

Ann Hematol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three atypical BCR/ABL transcripts detected simultaneously in a Philadelphia-positive acute lymphoblastic leukemia patient showing resistance to tyrosine kinase inhibitors.
Haimin Sun, Zeying Yan, Sujiang Zhang

Int J Hematol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated traditional Chinese and conventional medicine in the treatment of anemia due to lower-risk myelodysplastic syndrome: study protocol for a randomized placebo-controlled trial.
Qin Zheng, Haitao Xu, Luxi Song, Zeying Yan, Manqin Sun

Trials· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Ni₃S₂/Ni(OH)2 Directly Grown on Ni Foam for Battery-Type Electrode with Super Long Cycle Stability.
Chunli Guo, Li Wang, Zeying Yan, Yuyu Zhang, Jie Li

J Nanosci Nanotechnol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of Mesoporous Co₃O₄/NiCo₂O₄ Nanorods and Their Electrochemical Study.
Suxia Cui, Taotao Li, Chunli Guo, Linlin Wang, Chunchen Zhang, Zeying Yan

J Nanosci Nanotechnol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis